Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries
Public ClinicalTrials.gov record NCT01754480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Parenchymous Tissue Open Surgeries
Study identification
- NCT ID
- NCT01754480
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Instituto Grifols, S.A.
- Industry
- Enrollment
- 325 participants
Conditions and interventions
Conditions
Interventions
- Fibrin Sealant Grifols Biological
- Surgicel® Device
Biological · Device
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2013
- Primary completion
- Nov 30, 2015
- Completion
- Nov 30, 2015
- Last update posted
- Feb 7, 2017
2013 – 2015
United States locations
- U.S. sites
- 26
- U.S. states
- 20
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 224 | Loma Linda | California | 92354 | — |
| 214 | Los Angeles | California | 90033 | — |
| 213 | New Haven | Connecticut | 06520 | — |
| 223 | Augusta | Georgia | 30912 | — |
| 228 | Chicago | Illinois | 60611 | — |
| 227 | Goshen | Indiana | 46526 | — |
| 207 | Louisville | Kentucky | 40202 | — |
| 220 | New Orleans | Louisiana | 70112 | — |
| 229 | Bethesda | Maryland | 20889 | — |
| 201 | St Louis | Missouri | 63110 | — |
| 231 | Las Vegas | Nevada | 89102 | — |
| 200 | Albany | New York | 12208 | — |
| 211 | New York | New York | 10029 | — |
| 212 | New York | New York | 10032 | — |
| 230 | Charlotte | North Carolina | 28204 | — |
| 233 | Cincinnati | Ohio | 45219 | — |
| 400 | Hershey | Pennsylvania | 17033 | — |
| 218 | Philadelphia | Pennsylvania | 19102 | — |
| 204 | Philadelphia | Pennsylvania | 19107 | — |
| 205 | Charleston | South Carolina | 29425 | — |
| 217 | Memphis | Tennessee | 38104 | — |
| 206 | Nashville | Tennessee | 37232-7610 | — |
| 216, 219 | Houston | Texas | 77030 | — |
| 232 | Salt Lake City | Utah | 84132 | — |
| 226 | Charlottesville | Virginia | 22908 | — |
| 202 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01754480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01754480 live on ClinicalTrials.gov.